<pages><page bbox="0.000,0.000,720.000,540.000" id="10" mean_title="[27.1248, 474.86928888888895, 634.9029111111112, 515.7855555555556]" rotate="0">
<title archetypal_index="0" bbox="23.088,480.132,679.363,512.172" id="0" size="32.04">CYP2D6 Polymorphisms: Assessing Safety <textline bbox="23.088,480.132,679.363,512.172" colourspace="DeviceGray" font="Arial-BoldMT" ncolour="0" size="32.040">CYP2D6 Polymorphisms: Assessing Safety </textline>
</title>
<normal_text archetypal_index="1" bbox="73.848,292.041,371.007,320.001" id="4" size="27.96">conditions in clinical trials <textline bbox="73.848,292.041,371.007,320.001" colourspace="DeviceGray" font="TimesNewRomanPSMT" ncolour="0" size="27.960">conditions in clinical trials </textline>
</normal_text>
<enlisting archetypal_index="2" bbox="46.824,184.501,627.708,279.699" id="5" size="27.984">&#8226; Clinicians adjust dose and assess  <textline bbox="46.824,251.715,448.806,279.699" colourspace="DeviceGray" font="TimesNewRomanPSMT" ncolour="0" size="27.984">&#8226; Clinicians adjust dose and assess  </textline>
<normal_text bbox="73.848,184.501,627.708,246.061" id="6" size="27.96">safety/tolerability/efficacy without knowledge of  
metabolic status <textline bbox="73.848,218.101,627.708,246.061" colourspace="DeviceGray" font="TimesNewRomanPSMT" ncolour="0" size="27.960">safety/tolerability/efficacy without knowledge of  </textline>
<textline bbox="73.848,184.501,254.721,212.461" colourspace="DeviceGray" font="TimesNewRomanPSMT" ncolour="0" size="27.960">metabolic status </textline>
</normal_text>
</enlisting>
<picture archetypal_index="3" bbox="650.520,0.120,695.520,24.120" height="24" name="Image7" src="Image7.8.60x32.bmp" width="45">
</picture>
<picture archetypal_index="4" bbox="3.120,457.380,701.340,528.240" caption="&#8226; Initial clinical pharmacology studies above  &#10;proposed maximum dose &#10;&#8226; CYP2D6 genotype obtained under double-blind  " height="70" name="Image53" src="Image53.1940x197.bmp" width="698">
</picture>
</page>
</pages>